| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/30/2023 | 123.88% | Dawson James | → $3 | Initiates Coverage On | → Buy |
| 09/14/2018 | 273.13% | Maxim Group | → $5 | Initiates Coverage On | → Buy |
What is the target price for Genprex (GNPX)?
The latest price target for Genprex (NASDAQ: GNPX) was reported by Dawson James on January 30, 2023. The analyst firm set a price target for $3.00 expecting GNPX to rise to within 12 months (a possible 123.88% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Genprex (GNPX)?
The latest analyst rating for Genprex (NASDAQ: GNPX) was provided by Dawson James, and Genprex initiated their buy rating.
When is the next analyst rating going to be posted or updated for Genprex (GNPX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Genprex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Genprex was filed on January 30, 2023 so you should expect the next rating to be made available sometime around January 30, 2024.
Is the Analyst Rating Genprex (GNPX) correct?
While ratings are subjective and will change, the latest Genprex (GNPX) rating was a initiated with a price target of $0.00 to $3.00. The current price Genprex (GNPX) is trading at is $1.34, which is within the analyst's predicted range.